Literature DB >> 19067697

Acral lentiginous melanoma: conventional histology vs. three-dimensional histology.

V Lichte1, H Breuninger, G Metzler, H M Haefner, M Moehrle.   

Abstract

BACKGROUND: Patients with acral lentiginous melanoma (ALM) seem to have a poor prognosis. ALMs represent 4-10% of cutaneous melanomas in white populations. Surgery is mostly based on conventional histological evaluation. With micrographic surgery, continuously spreading tumours can be excised with smaller excision margins for better cosmesis and function.
OBJECTIVES: Clinical parameters and surgical strategies influencing the prognosis of patients with ALM were evaluated.
METHODS: Two hundred and forty-one patients (44% male, 56% female) with stage I/II ALM were recorded during 1980-2006. One hundred and thirty-three patients underwent complete histology of three-dimensional excision margins (3D histology) using the paraffin technique. Risk factors for disease-specific and recurrence-free survival were estimated.
RESULTS: Patients were aged 26-87 years (median 63) with median tumour thickness of 2.0 mm. The median follow-up was 41 months. Multivariate analysis identified ulceration, conventional histology and tumour thickness as risk factors for recurrence-free and disease-specific survival. Using 3D histology, excision margins were significantly smaller (median 7 vs. 20 mm) without an increased risk of local recurrences. Patients with 3D histology had a 5-year survival of 81% compared with 63% with conventional histology. Retrospective analysis with immunohistological methods (anti-Melan-A) could improve the diagnostic specificity in detecting further melanocytic cell nests.
CONCLUSIONS: Clinical and surgical risk factors seem to have different influences on the outcome of ALM. 3D histology allows reduction of excision margins by two-thirds without an increased risk of local recurrences and with better prognosis. 3D immunohistology could be a valuable diagnostic tool to reduce the rate of local recurrences.

Entities:  

Mesh:

Year:  2008        PMID: 19067697     DOI: 10.1111/j.1365-2133.2008.08954.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

Review 1.  [Operative management of acral skin tumors].

Authors:  H Breuninger
Journal:  Hautarzt       Date:  2009-07       Impact factor: 0.751

2.  [Operative therapy of acral melanomas].

Authors:  M Möhrle; V Lichte; H Breuninger
Journal:  Hautarzt       Date:  2011-05       Impact factor: 0.751

3.  Nomogram for Predicting Overall Survival in Acral Lentiginous Melanoma: A Population-based Study.

Authors:  Tingting Yin; Yuhui Zhao; Ying Yang; Huaxiu Xu; Dongxiang Zheng; Jun Lyu; Guanglei Fu
Journal:  Int J Gen Med       Date:  2021-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.